Skip to main content
. 2012 Feb 20;1(1):16–26. doi: 10.1161/JAHA.111.000018

Figure 2.

Figure 2.

ORs for 24-month mortality associated with the number of guideline-recommended therapies received at baseline. Analysis includes all patients from the case-control population (N=4128). The number (%) of patients receiving each number of therapies at baseline was as follows: 0 or 1, 238 (5.8%); 2, 712 (17.3%); 3, 1327 (32.2%); 4, 1123 (27.2%); and 5, 6, or 7, 728 (17.6%). OR indicates odds ratio.